journal article
Open Access
May 01, 2025
Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis
Abstract
ABSTRACTBackground and PurposeManagement of autoimmune encephalitis (AE) is challenging due to a lack of reliable biomarkers. We here assess the combination of glial fibrillary acid protein (GFAP) and neurofilament (NfL) as biomarkers for diagnosis and disease monitoring of AE.MethodsGFAP and NfL CSF levels (cGFAP, cNfL) of 42 AE patients were correlated with CSF markers of neuroinflammation. NfL/GFAP ratios were compared between patients with stable and active AE, stable and active multiple sclerosis (MS), and patients undergoing diagnostic lumbar puncture without evident pathological alterations (controls).ResultsIn patients with AE, cGFAP levels showed strong correlations with albumin and IgG quotients and moderate correlations with CSF cell count; cNfL levels showed weak correlations with albumin quotients. cGFAP and cNfL levels showed no significant differences between patients with and without epileptic activity or inflammatory MRI lesions. Both sNfL and sGFAP correlated with the Clinical Assessment Scale in Autoimmune Encephalitis. Compared to NfL or GFAP alone, the NfL/GFAP ratio from CSF or serum led to a clearer separation of AE from MS patients and controls. Furthermore, serum NfL/GFAP ratios better discriminated active from stable AE.ConclusioncGFAP levels indicate intrathecal inflammatory processes in patients with active AE to a stronger degree than cNfL levels. Serum NfL/GFAP ratios recognize active AE, suggesting this ratio identifies AE patients with CNS‐compartmentalized neuronal injury (autoantibody‐mediated or cytotoxic) behind a relatively intact blood–brain barrier. Our findings indicate that the NfL/GFAP ratio can function as a blood‐based biomarker, aiding clinicians with diagnosis and disease management of AE.
Topics
No keywords indexed for this article. Browse by subject →
References
24
[5]
Li J. "Cerebrospinal Fluid Light and Heavy Neurofilament Level Increased in Anti‐N‐Methyl‐d‐Aspartate Receptor Encephalitis" Brain and Behavior: A Cognitive Neuroscience Perspective (2019) 10.1002/brb3.1354
[16]
[18]
[19]
[20]
[22]
[24]
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Andrea L. Benedet, Marta Milà-Alomà, Agathe Vrillon et al.
JAMA Neurology
10.1001/jamaneurol.2021.3671
Metrics
3
Citations
24
References
Details
- Published
- May 01, 2025
- Vol/Issue
- 32(5)
- License
- View
Authors
Funding
Deutsche Forschungsgemeinschaft
Award: 213904703
Else Kröner-Fresenius-Stiftung
Award: TransMed Jumpstart Program
Cite This Article
Johannes Piepgras, Marlene L. Piepgras, Falk Steffen, et al. (2025). Glial Fibrillary Acid Protein Reflects Disease Activity in Autoimmune Encephalitis. European Journal of Neurology, 32(5). https://doi.org/10.1111/ene.70207
Related